ATE529124T1 - Verwendung des engrailed homeodomänen-proteins als anxiolytikum - Google Patents

Verwendung des engrailed homeodomänen-proteins als anxiolytikum

Info

Publication number
ATE529124T1
ATE529124T1 AT07731062T AT07731062T ATE529124T1 AT E529124 T1 ATE529124 T1 AT E529124T1 AT 07731062 T AT07731062 T AT 07731062T AT 07731062 T AT07731062 T AT 07731062T AT E529124 T1 ATE529124 T1 AT E529124T1
Authority
AT
Austria
Prior art keywords
anxiolytic
homeodomain protein
engrailed
engrailed homeodomain
protein
Prior art date
Application number
AT07731062T
Other languages
English (en)
Inventor
Alain Prochiantz
Michel Volovitch
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE529124T1 publication Critical patent/ATE529124T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT07731062T 2006-02-28 2007-02-28 Verwendung des engrailed homeodomänen-proteins als anxiolytikum ATE529124T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0601749A FR2897780B1 (fr) 2006-02-28 2006-02-28 Utilisation de la proteine a homeodomaine engrailed comme anxiolytique
PCT/FR2007/000360 WO2007099227A2 (fr) 2006-02-28 2007-02-28 Utilisation de la proteine a homeodomaine engrailed comme anxiolytique

Publications (1)

Publication Number Publication Date
ATE529124T1 true ATE529124T1 (de) 2011-11-15

Family

ID=36950419

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07731062T ATE529124T1 (de) 2006-02-28 2007-02-28 Verwendung des engrailed homeodomänen-proteins als anxiolytikum

Country Status (8)

Country Link
US (1) US8575105B2 (de)
EP (1) EP1993587B1 (de)
JP (1) JP5205282B2 (de)
AT (1) ATE529124T1 (de)
CA (1) CA2643722C (de)
ES (1) ES2376362T3 (de)
FR (1) FR2897780B1 (de)
WO (1) WO2007099227A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013128239A1 (en) 2012-02-29 2013-09-06 Centre National De La Recherche Scientifique Use of engrailed for increasing dopamine synthesis by dopaminergic neurons
EP3352777B1 (de) 2015-09-23 2021-09-15 Centre National De La Recherche Scientifique Engrailed zur verwendung in der behandlung von dna-schäden in einem patienten der an parkinson leidet
IL308224A (en) * 2021-05-04 2024-01-01 2N Pharma Aps Diazepane derivatives, processes for their preparation, and uses thereof for the amelioration, prevention and/or treatment of mental and neurological diseases
JP2026503094A (ja) 2023-01-13 2026-01-27 ブレインエバー 安定化エングレイルドタンパク質水性組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662698A1 (fr) * 1990-06-05 1991-12-06 Centre Nat Rech Scient Nouveaux facteurs de croissance neurotropes comprenant un peptide homeoboite.
US5888762A (en) 1990-06-05 1999-03-30 Centre National De La Recherche Scientifique (Cnrs) Neurotropic growth factors comprising a homeobox peptide
FR2739621B1 (fr) 1995-10-05 1997-12-05 Centre Nat Rech Scient Peptides utilisables comme vecteurs pour l'adressage intracellulaire de molecules actives
FR2816845B1 (fr) 2000-11-20 2006-10-20 Centre Nat Rech Scient Vecteurs de transport a travers un epithelium a jonctions serrees
FR2849603B1 (fr) 2003-01-07 2006-09-08 Centre Nat Rech Scient Composition pour le transport intracellulaire de macromolecules ou particules biologiques
FR2855178B1 (fr) * 2003-05-20 2005-08-05 Centre Nat Rech Scient Peptides modulateurs de l'activite du facteur de transcription engrailed
WO2005007812A2 (en) * 2003-07-03 2005-01-27 University Of Medicine And Dentistry Of New Jersey Genes as diagnostic tools for autism

Also Published As

Publication number Publication date
CA2643722A1 (fr) 2007-09-07
JP2009529001A (ja) 2009-08-13
FR2897780B1 (fr) 2008-05-23
US8575105B2 (en) 2013-11-05
EP1993587B1 (de) 2011-10-19
JP5205282B2 (ja) 2013-06-05
EP1993587A2 (de) 2008-11-26
FR2897780A1 (fr) 2007-08-31
CA2643722C (fr) 2014-07-08
WO2007099227A2 (fr) 2007-09-07
US20110294739A1 (en) 2011-12-01
WO2007099227A3 (fr) 2007-10-18
ES2376362T3 (es) 2012-03-13

Similar Documents

Publication Publication Date Title
EA200971077A1 (ru) Гетероциклические модуляторы киназы
EA200870185A1 (ru) Комбинации ингибиторов ang2 и vegf
CL2012000768A1 (es) Compuestos derivados de acido l-glutamico y l-glutamina marcados con [18f]; procedimiento de preparacion; y su uso para el diagnostico de enfermedades tumorales.
CY1118601T1 (el) Αλκυλαμινο-υποκατεστημενες δικυανοπυριδινες και προφαρμακα τυπου εστερα αμινοξεος αυτων
TW200716647A (en) Synthesis of (R)-N-methylnaltrexone
ECSP077360A (es) Compuestos sulfonamida
CL2011000846A1 (es) Compuestos heterociclicos sustituidos; composicion farmaceutica; y su uso para el tratamiento de la hepatitis c.
MX384206B (es) Formulaciones de inhibidores de dpp iv
PA8842101A1 (es) Heteroarilos sustituidos
CL2009001032A1 (es) Combinaciones de compuestos activos para controlar plagas animales; uso de las combinaciones; y procedimientos para controlar plagas animales.
EA201190053A1 (ru) Агонисты рецептора gpr120 и их применение
BRPI0917017B8 (pt) inibidores de pirrol de s-nitrosoglutationa redutase como agentes terapêuticos
EA201101522A1 (ru) Способы лечения болезней с использованием эпиметаболического переключателя (коэнзим q10)
EA201290964A1 (ru) Пептидные конъюгаты агонистов рецептора glp-1 и их применение
BRPI0915084B8 (pt) composto, e, composição farmacêutica
EA201170349A1 (ru) Модуляторы mif
EA201100302A1 (ru) Лечение диабета у пациентов, для которых лечение метформином является неприемлемым
MA32161B1 (fr) Formes de rifaximine et utilisations de celles-ci
GT201200189A (es) Antagonistas de pcsk9
MX2009013194A (es) Proteinas de fusion del receptor para productos finales de glicacion avanzada.
CL2009000402A1 (es) Compuestos derivados de 2-amino-acetamida sustituida; composicion farmaceutica; utiles en el tratamiento de enfermedades pulmonares, enfermedad reumatica, enfermedad autoinmune, entre otras.
ES2386734T8 (es) Ácidos fenoxiacéticos como activadores de PPAR-delta.
ATE552336T1 (de) Herstellung biologisch aktiver proteine
CL2008002295A1 (es) Compuestos derivados de tiazolida sustituidos con alquilsulfonilos; composicion farmaceutica; y uso para el tratamiento de la hepatitis c.
CL2011002835A1 (es) Compuestos derivados de 7-aza-espiro[3.5]nonano-7-carboxilatos; procedimiento de preparacion; compuestos intermediarios; composicion farmaceutica; y su uso para tratar dolores agudos o cronicos de tipos neurogeno, asociados a enfermedades inflamatorias, entre otros.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties